Real-time enrollment status for this cancer clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 1:42 PM UTC
| NCT Number | NCT02445222 |
| Recruiting Status | Recruiting |
| Condition | Cancer |
| Phase | PHASE3 |
| Target Enrollment | 1,105 participants |
| Active Locations | 44 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | October 2, 2026 (1 week ago) |
As of October 12, 2026: Clinical trial NCT02445222 is currently recruiting participants. This phase3 study for cancer is actively seeking new participants at 44 locations across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT02445222 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 44 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT02445222 was last updated 1 week ago (October 2, 2026). HelloStudys verifies this status automatically.